Gastroenterology Specialty Pharmacy

Yes. Accord Specialty Pharmacy dispenses a full range of biologic therapies for inflammatory bowel disease, including TNF inhibitors, integrin antagonists, and IL-12/23 and IL-23 inhibitors. We assist with prior authorization and manufacturer enrollment for all dispensed therapies.

Our team works with the prescriber and patient to map out the dosing schedule at therapy initiation. We schedule deliveries to align with induction doses and transition to maintenance intervals, and send proactive refill reminders to prevent gaps in therapy.

Yes. We enroll patients in manufacturer copay assistance programs for all major GI biologics, which can reduce out-of-pocket costs significantly for commercially insured patients. For patients who do not qualify for copay programs, we identify patient assistance and foundation resources.

Yes. Accord dispenses Zymfentra (infliximab-dyyb), the subcutaneous form of infliximab approved for Crohn's disease and ulcerative colitis after adequate induction with IV infliximab. Our team assists with prior authorization and transition coordination from infusion to subcutaneous therapy.

Download the Gastroenterology referral form from our Referral Forms page. Complete the patient information, prescriber details, and prescription sections, then fax the completed form along with required documentation to 386-385-7871. We confirm receipt within one business day.

Yes. Accord ships inflammatory bowel disease specialty medications to patients in states where Accord holds an active pharmacy license. Biologics requiring refrigeration are packaged with validated cold-chain materials to protect the medication throughout transit.